HMGB1 and brain ischemia: In addition, Chang et al. previously reported that tetramethylpyrazine elevated Nrf2/HO-1 expression and inhibited HMGB1/TLR4 expression, promoted endogenous anti-inflammatory defense capacity, and attenuated pro-inflammatory responses in cerebral ischemia [47].